Marshall Wace
PMC

Marshall Wace’s PharMerica Corporation PMC Stock Holding History

Marshall Wace’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-30,466
Closed -$751K – 1251
2016
Q2 		$751K Buy
+30,466
New +$756K 0.01% 761
2016
Q1 		– Sell
-8,940
Closed -$313K – 1295
2015
Q4 		$313K Buy
+8,940
New +$280K ﹤0.01% 871

Other funds holding PMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Marshall Wace's PMC Position: Q3 2016 in Review

Marshall Wace sold out of PharMerica Corporation (PMC) in Q3 2016, closing a stake of 30,466 shares — an estimated $751K sold.

Marshall Wace first reported a position in PMC in Q4 2015 and held it in 2 quarters. The position peaked at $751K in Q2 2016. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

  • Marshall Wace reported no remaining PharMerica Corporation position as of Q3 2016 after selling out during the quarter.
  • Marshall Wace sold 30,466 PharMerica Corporation shares in Q3 2016, an estimated $751K.
  • Marshall Wace first reported a position in PharMerica Corporation in Q4 2015 and held it in 2 quarters.
  • Marshall Wace's PharMerica Corporation position peaked at $751K in Q2 2016.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.